Offer - Urjas Oil for just ₹ 1
Nebistar LN 2.5 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Nebistar LN 2.5 Tablet safe for pregnant women?
No research has been done to ascertain the safety of Nebistar LN in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.
Is the use of Nebistar LN 2.5 Tablet safe during breastfeeding?
There is no research available on the side effects of Nebistar LN in breastfeeding women. Therefore, its impact is unknown.
What is the effect of Nebistar LN 2.5 Tablet on the Kidneys?
Very few cases of side effects of Nebistar LN on kidney have been reported.
What is the effect of Nebistar LN 2.5 Tablet on the Liver?
Nebistar LN may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Nebistar LN 2.5 Tablet on the Heart?
You may experience side effects on your heart after taking Nebistar LN. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
If you are suffering from any of the following diseases, you should not take Nebistar LN 2.5 Tablet unless your doctor advises you to do so -
Is this Nebistar LN 2.5 Tablet habit forming or addictive?
No, there is no any evidence that Nebistar LN 2.5 Tablet is addictive.
Interaction between Food and Nebistar LN 2.5 Tablet
Taking Nebistar LN 2.5 Tablet with food is safe.
Interaction between Alcohol and Nebistar LN 2.5 Tablet
Information about the interaction of Nebistar LN 2.5 Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897
